Cover: Management of Heart Failure

Management of Heart Failure

Published In: JAMA, The Journal of the American Medical Association, v. 272, no. 19, Nov. 16, 1994, p. 1528-1534

Posted on 1994

by David William Baker, Robert Jones, James S. Hodges, Barry M. Massie, Marvin A. Konstam, Eric A. Rose

Discusses the role of revascularization in the treatment of patients with severe heart failure. It concludes that CABG improves three-year survival rates in patients with moderate to severe left ventricular dysfunction and limiting angina. It is not clear, however, whether patients whose predominant symptom is heart failure rather than angina benefit from CABG, or how much ischemia is required to justify surgical intervention. In addition, the article contends that clinical outcomes after angioplasty have not been sufficiently studied to determine angioplasty's relative risks and benefits compared with those of CABG.

This report is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.